ATE418980T1 - Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission - Google Patents

Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission

Info

Publication number
ATE418980T1
ATE418980T1 AT05794149T AT05794149T ATE418980T1 AT E418980 T1 ATE418980 T1 AT E418980T1 AT 05794149 T AT05794149 T AT 05794149T AT 05794149 T AT05794149 T AT 05794149T AT E418980 T1 ATE418980 T1 AT E418980T1
Authority
AT
Austria
Prior art keywords
treatment
group
neurotransmission
prophylaxis
improper
Prior art date
Application number
AT05794149T
Other languages
English (en)
Inventor
Saizieu Antoine De
Ann Fowler
Regina Goralczyk
Bernd Mussler
Goede Schueler
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE418980T1 publication Critical patent/ATE418980T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/117Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • A23L7/126Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT05794149T 2004-10-22 2005-10-21 Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission ATE418980T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04025165 2004-10-22

Publications (1)

Publication Number Publication Date
ATE418980T1 true ATE418980T1 (de) 2009-01-15

Family

ID=36154615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05794149T ATE418980T1 (de) 2004-10-22 2005-10-21 Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission

Country Status (9)

Country Link
US (1) US8044094B2 (de)
EP (1) EP1802298B1 (de)
JP (2) JP2008517879A (de)
KR (1) KR20070068400A (de)
CN (2) CN101043886A (de)
AT (1) ATE418980T1 (de)
DE (1) DE602005012132D1 (de)
ES (1) ES2320686T3 (de)
WO (1) WO2006042441A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077972A1 (ja) * 2005-01-21 2006-07-27 Arkray, Inc. メタボリックシンドローム改善剤、ならびにそれを含む医薬、サプリメント、機能性食品および食品添加物
US8329239B2 (en) * 2009-03-03 2012-12-11 Givandan S.A. Off-taste masking
US8729279B2 (en) 2010-03-03 2014-05-20 Erina Co., Inc. Agent for promoting osteoblast differentiation, pharmaceutical composition for promoting bone formation, and food for special dietary use containing auraptene analog as active ingredient
CN102267966B (zh) * 2011-08-01 2013-02-27 华中科技大学 取代的苯并吡喃酮类衍生物及其应用
JP5945861B2 (ja) * 2011-09-29 2016-07-05 学校法人松山大学 医薬組成物及びその製造方法
JP2018110572A (ja) * 2017-01-13 2018-07-19 国立大学法人千葉大学 DGKδノックアウトマウス及びこれを用いた方法
CN108478568B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种香豆素类化合物在制备单胺氧化酶抑制剂中的用途
CN116650476B (zh) * 2023-05-30 2025-09-09 南华大学附属第一医院 一种化合物、组合物及其在制备治疗心脏病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713490A (de) 1967-04-14 1968-10-10
GB1497161A (en) 1975-07-19 1978-01-05 Beecham Group Ltd Naphthyl derivatives
JPH04128224A (ja) 1989-11-28 1992-04-28 Sankyo Co Ltd クマリン環を有する脳循環代謝改善薬
JP2004131432A (ja) * 2002-10-11 2004-04-30 Kumamoto Technology & Industry Foundation 悪性腫瘍抑制剤
EP1588705A1 (de) 2004-04-21 2005-10-26 INTE:LIGAND Software-Entwicklungs und Consulting GmbH Verwendung von Cumarinderivaten
WO2006024545A1 (en) 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes

Also Published As

Publication number Publication date
US8044094B2 (en) 2011-10-25
WO2006042441A3 (en) 2006-07-13
JP2008517879A (ja) 2008-05-29
WO2006042441A2 (en) 2006-04-27
KR20070068400A (ko) 2007-06-29
EP1802298B1 (de) 2008-12-31
DE602005012132D1 (de) 2009-02-12
JP2013063974A (ja) 2013-04-11
EP1802298A2 (de) 2007-07-04
US20070293563A1 (en) 2007-12-20
CN101703239A (zh) 2010-05-12
ES2320686T3 (es) 2009-05-27
CN101043886A (zh) 2007-09-26

Similar Documents

Publication Publication Date Title
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
ATE453636T1 (de) Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
DE602004013563D1 (de) Rantagonisten
EP1793827A4 (de) Tricyclische anilid-spirohydantoin-cgrp-rezeptorantagonisten
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
MY144634A (en) 3-or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
ATE418980T1 (de) Neue mittel zur prophylaxe und behandlung von erkrankungen in zusammenhang mit beeinträchtigter neurotransmission
EA200601462A1 (ru) Соединения для лечения заболеваний
BG108180A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
ATE543813T1 (de) Neue benzopyranderivate als kaliumkanalöffner
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE437636T1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
EA200601510A1 (ru) Производные фенилэтаноламина в качестве бета-2-агонистов
ATE471142T1 (de) Aroma- und duftstoffzusammensetzungen
FR2852847B1 (fr) Composition renfermant une superoxyde dismutase et un inhibiteur de la 5-lipoxygenase selectionne et applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties